AngioDynamics, Inc. Restructuring Reserve, Settled without Cash
AngioDynamics, Inc. (ANGO) reported Restructuring Reserve, Settled without Cash of $337.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveSettledWithoutCash2 · last filed 2026-07-14
- AngioDynamics, Inc. restructuring reserve, settled without cash for the quarter ending 2024-05-31 was $5.77M.
- AngioDynamics, Inc. restructuring reserve, settled without cash for the quarter ending 2019-05-31 was $0.00.
- AngioDynamics, Inc. restructuring reserve, settled without cash for the quarter ending 2019-02-28 was $9.00K, a 76.92% decline year-over-year.
- AngioDynamics, Inc. restructuring reserve, settled without cash for the quarter ending 2018-08-31 was $0.00, a 100.00% decline year-over-year.
- AngioDynamics, Inc. restructuring reserve, settled without cash for fiscal 2026 was $337.00K, a 90.03% decline from fiscal 2025.
- AngioDynamics, Inc. restructuring reserve, settled without cash for fiscal 2025 was $3.38M.
- AngioDynamics, Inc. restructuring reserve, settled without cash for fiscal 2019 was $9.00K, a 96.74% decline from fiscal 2018.
- AngioDynamics, Inc. restructuring reserve, settled without cash for fiscal 2018 was $276.00K, a 155.56% increase from fiscal 2017.
| Period end | Restructuring Reserve, Settled without Cash 3 month | Restructuring Reserve, Settled without Cash 6 month | Restructuring Reserve, Settled without Cash 9 month | Restructuring Reserve, Settled without Cash 12 month |
|---|---|---|---|---|
| 2026-05-31 | $337.00K 10-K · filed 2026-07-14 | |||
| 2025-05-31 | $3.38M 10-K · filed 2025-07-18 | |||
| 2024-05-31 | $5.77M 10-K · filed 2024-07-25 | |||
| 2019-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $9.00K derived: sum of 2 quarters · filed 2020-08-10 | $9.00K 10-K · filed 2020-08-10 | |
| 2019-02-28 | $9.00K 10-Q · filed 2019-04-02 | $9.00K 10-Q · filed 2019-04-02 | ||
| 2018-08-31 | $0.00 10-Q · filed 2018-10-01 | $0.00 derived: sum of 2 quarters · filed 2020-08-10 | $39.00K derived: sum of 3 quarters · filed 2020-08-10 | $246.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2018-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $39.00K derived: sum of 2 quarters · filed 2020-08-10 | $246.00K derived: sum of 3 quarters · filed 2020-08-10 | $276.00K 10-K · filed 2020-08-10 |
| 2018-02-28 | $39.00K 10-Q · filed 2018-04-05 | $246.00K derived: sum of 2 quarters · filed 2018-04-05 | $276.00K 10-Q · filed 2018-04-05 | |
| 2017-11-30 | $207.00K 10-Q · filed 2018-01-05 | $315.00K 10-Q · filed 2018-01-05 | ||
| 2017-08-31 | $108.00K 10-Q · filed 2017-09-29 | |||
| 2017-05-31 | $108.00K 10-K · filed 2019-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |